Filing a breast implant lawsuit may be an option for women who have suffered serious complications allegedly related to leaking or faulty silicone implants. Mentor Worldwide, one of only three companies authorized to market silicone-filled breast implants in the U.S., has already been named a defendant in two recently-filed cases. However, some legal experts believe that thousands of women may be eligible to file claims of their own.
Bernstein Liebhard LLP is now evaluating potential lawsuits involving illness and injuries that may be associated with silicone breast implants. Women pursuing similar cases claim that defective or ruptured implants can cause a wide range of complications and side effects, including:
If you experienced any of these health issues following breast augmentation or reconstruction with silicone implants, please call (888) 994-5118 to discuss your case with a member of our legal team today.
Silicone breast implants were brought to market in 1962, before the law required the U.S. Food & Drug Administration (FDA) to review and approve medical devices for safety and effectiveness. In the 1980s and 1990s, tens of thousands of women filed breast implant lawsuits for autoimmune and connective tissue disorders allegedly caused by leaking silicone implants. Eventually, Dow Corning and other defendants agreed to pay billions to settle the claims.
In 1992, the FDA imposed a near-virtual ban on silicone gel implants that lasted for 14 years. Since lifting the ban, the agency has only approved five silicone breast implants for use in the U.S.:
Despite their controversial history, silicone implants are the preferred option for women undergoing breast augmentation and reconstruction. However, recent lawsuits have once again raised concerns about their potential safety hazards:
In March 2017, the FDA confirmed a small, but significant risk of anaplastic large cell lymphoma (ALCL) among breast implant patients, after logging more 350 reports of the cancer in patients with silicon or saline devices. The agency had been investigating the potential for breast implant cancer since 2011. According to the March 2017 update, at least 9 women had died as result of the rare form of non-Hodgkin’s lymphoma.
ALCL is a cancer that affects the cells of the immune system. In breast implant patients, the disease is generally seen in the breast, usually in scar tissue around the device. However, ALCL can also occur in the skin or lymph nodes. The data reported to the FDA suggested that the disease was more likely to occur in patients with textured implants, rather than those with smooth devices.
ALCL is treatable if detected early. The FDA is advising women to monitor their breast implants and contact their doctors promptly if they notice pain, swelling or any changes in or around the device.
Women who successfully pursue a breast implant lawsuit may be able to recover financial compensation for all of their injury-related damages, including:
If you think silicone breast implants made you or a woman you love sick, please call (888) 994-5118 to ensure that your legal rights are protected.
Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.